You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

induction regimen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML Trial in Guanzhou (CLAG)

Not yet recruiting
  • AML
  • CLAG
  • Guanzhou, Guangdong, China
  • +1 more
May 16, 2023

Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 16, 2022

PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

Not yet recruiting
  • PD-1 Antibody
  • +3 more
  • L-DEP and PD-1 antibody
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 8, 2023

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in combination with azacitidine and CAG
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022

Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

Not yet recruiting
  • Renal Transplant Rejection
  • Induction Therapy
  • (no location specified)
Sep 22, 2022

Extrathoracic Sarcoidosis Trial in France (Infliximab, Placebo)

Completed
  • Extrathoracic Sarcoidosis
  • Bobigny, France
  • +9 more
Nov 15, 2021

Type 1 Diabetes Trial in Duarte (Allogenic Human Islet Cells, Immunosuppressive Agents, Gastrin 17)

Recruiting
  • Type 1 Diabetes Mellitus
  • Allogenic Human Islet Cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Sep 14, 2022

Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)

Recruiting
  • Kidney Transplantation
  • TCD601
  • San Francisco, California
  • +4 more
Oct 28, 2022

Metastatic Urothelial Carcinoma Trial in Ramat Gan (Tumor Infiltrating Lymphocytes (TIL), Proleukin)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Ramat Gan, Israel
    Sheba Medical Center
Feb 8, 2021

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Apr 29, 2022

Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)

Recruiting
  • Pancreatic Cancer
  • LDR
  • +2 more
  • Modena, MO, Italy
    Azienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022

HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)

Not yet recruiting
  • HPV-Negative Squamous Cell Carcinoma
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023

Renal Insufficiency, Kidney Transplantation Trial in Amsterdam, Groningen, Leiden (tacrolimus OD, mycophenolic acid,

Completed
  • Renal Insufficiency
  • Kidney Transplantation
  • tacrolimus OD, mycophenolic acid, prednisolone
  • Amsterdam, Netherlands
  • +2 more
Dec 20, 2021

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • No intervention
  • Hefei, Anhui, China
  • +11 more
Jun 22, 2022

Lupus Nephritis Trial in Bucharest (Rituximab, Mycophenolate Mofetil, Cyclophosphamide)

Recruiting
  • Lupus Nephritis
  • Bucharest, Romania
    Fundeni Clinical Institute
Mar 2, 2022

Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Tumors Trial in Shanghai (chemo TP regimen combined with Toripalimab)

Recruiting
  • Laryngeal Cancer
  • +2 more
  • chemotherapy TP regimen combined with Toripalimab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 2, 2022

Regimen in ANCA-associated Vasculitis

Terminated
  • Granulomatosis, Wegener's
  • Microscopic Polyangiitis
  • blood specimen
  • Lyon, France
  • +3 more
Nov 12, 2020

Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,

Recruiting
  • Hemophagocytic Syndrome
  • T/NK-Cell Lymphoma
  • Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Aug 3, 2021

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

Active, not recruiting
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +49 more
Dec 26, 2022

Renal Transplantation Trial in United States (Alemtuzumab, rabbit antithymocyte globulin, Belatacept)

Completed
Has Results
  • Renal Transplantation
  • San Francisco, California
  • +7 more
Jul 8, 2021

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 1, 2021

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +32 more
Oct 8, 2021